Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| MEDICAL PROPERTIES TRUST INCMPW · Entity 4372 | Executive Vice President & COO | July 06, 2023 | July 10, 2023 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
MEDICAL PROPERTIES TRUST INC
Report date July 06, 2023 · Filed July 10, 2023
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common stock, par value $0.001SEC Table I · non-derivative | Direct | 2,056,647 |
Reported balance
After 2023-07-06 transaction · row 1
1 source rowRow 1 · 2023-07-06 · Tax withholding · Disposed 8,408 · Balance 2,056,647 F1: Represents shares withheld upon vesting of restricted stock to satisfy tax withholding obligations. This does not constitute a sale transaction. |
Filing footnotes · ownership attribution and instrument terms
F1: Represents shares withheld upon vesting of restricted stock to satisfy tax withholding obligations. This does not constitute a sale transaction.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| September 02, 2016 Filed Sep 7, 2016 20:59 UTC | MEDICAL PROPERTIES TRUST INC MPW · Entity 4372 | GrantCommon stock, par value $0.001 | 126,334 | $0.00 | $0.00 |
DisclosureSEC source: 0001287865-16-000038 · primary_doc.xml · nonDerivative · entry 2 McLean Emmett E · CIK 0001331446 · Executive Vice President & COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 867,169 F2 · shares: Up to 50% of the shares may be earned based on the achievement of a three-year cumulative total shareholder return as compared to pre-established multi-level returns set by our compensation committee. If the cumulative shareholder return is less than or equal to 27.0% for the three-year period, no shares will be earned, whereas if a total shareholder return of 35.0% or greater is achieved for the same period, then 100% of these shares will be earned. At the end of the three-year performance period, any earned shares will be subject to an additional two years of ratable time-based vesting on an annual basis. Dividends are paid on these shares only upon achievement of the performance measures. F3 · shares: The remaining 50% of the shares will be earned similar to that described above; however, the performance measure is against the MSCI US REIT Index (Index). If our total shareholder return over the three-year cumulative period is less than the Index minus 3%, then no shares will be earned, whereas if our total shareholder return is greater than the Index plus 3% for the same period, then 100% of these shares will be earned. At the end of the three-year performance period, any earned shares will be subject to an additional two years of ratable time-based vesting on an annual basis. Dividends are paid on these shares only upon achievement of the performance measures. Read SEC document |
| September 02, 2016 Filed Sep 7, 2016 20:59 UTC | MEDICAL PROPERTIES TRUST INC MPW · Entity 4372 | GrantCommon stock, par value $0.001 | 31,583 | $0.00 | $0.00 |
DisclosureSEC source: 0001287865-16-000038 · primary_doc.xml · nonDerivative · entry 1 McLean Emmett E · CIK 0001331446 · Executive Vice President & COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 740,835 F1 · shares: Shares vest ratably at the beginning of each of the 12 calendar quarters ending Marcy 31, 2019; dividends are paid currently. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.